3/13
08:16 am
prld
Prelude Therapeutics Incorporated (NASDAQ: PRLD) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
High
Report
Prelude Therapeutics Incorporated (NASDAQ: PRLD) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
3/13
08:16 am
prld
Prelude Therapeutics Incorporated (NASDAQ: PRLD) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
High
Report
Prelude Therapeutics Incorporated (NASDAQ: PRLD) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
3/13
05:18 am
prld
Rating for PRLD
High
Report
Rating for PRLD
3/13
05:18 am
prld
Rating for PRLD
High
Report
Rating for PRLD
2/20
07:29 am
prld
Prelude Therapeutics Incorporated (NASDAQ: PRLD) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock.
Medium
Report
Prelude Therapeutics Incorporated (NASDAQ: PRLD) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock.